Tag: biotechnology
-
Trial Set for Covid-19 Antibodies in Long-Term Care
Two companies and NIH are beginning a clinical trial of synthetic antibodies to both treat and prevent Covid-19 infections among people in long-term care.
-
NIH Issues Contracts for Faster Covid-19 Diagnostics
National Institutes of Health awarded contracts to seven companies for higher-speed Covid-19 detection tests to ease current reporting delays.
-
Two Covid-19 Vaccines Show Preclinical Immune Responses
Two candidate vaccines to prevent Covid-19 infections show they generate immune protections in lab monkeys, with one vaccine for 13 weeks.
-
Trial Underway for Seasonal Flu Antibody Therapy
A participant in an early-stage clinical trial received the first dose of an experimental synthetic antibody produced in cattle to treat seasonal influenza.
-
Neuro Disease Start-Up Raises $73M in Early Funds
A company developing new therapies for neurodegenerative diseases officially began operations, staked to $73 million raised in its first venture round.
-
Synthetic Protein Maker Raises $91.3M in Venture Funds
A company creating animal-free designer proteins for skin care products is raising more than $91 million in its second venture funding round.
-
Venture Funding Down in 2020, Life Sciences Stay Hot
For the first half of 2020, venture investing declined compared to 2019, but life science and biotechnology investments continued growing for the year.
-
Synthetic Protein Designed to Boost Covid-19 Vaccines
Researchers in Texas designed a synthetic version of a protein found on Covid-19 viruses that can make it easier to produce more vaccines.
-
Advanced Solid Tumor Precision Meds. Trial Begins
A clinical trial is underway testing a treatment for advanced-stage cancers that blocks amino acids allowing nutrients to feed the growth of solid tumors.
-
Start-Up Developing Inside-Cell Delivery, Gains $28.5M
A new company spun-off from Harvard University is developing techniques for delivering advanced genetic and protein therapies directly inside cells.